 Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores
Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore
Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores
LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26
Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26 Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores
Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores 
              The Board of Directors of Glenmark Pharmaceuticals Ltd, at its Meeting held on May 12, 2016 allotted 8,000 equity shares to the employees of the Company on exercise of options granted to them pursuant to ESOS 2003.
The Nomination and Remuneration Committee of the Company, at its meeting held on May 12, 2016 has cancelled 27,500 stock options pursuant to ESOS 2003.
Shares of GLENMARK PHARMACEUTICALS LTD. was last trading in BSE at Rs.858.1 as compared to the previous close of Rs. 857.05. The total number of shares traded during the day was 42460 in over 2339 trades.
The stock hit an intraday high of Rs. 868.5 and intraday low of 855.45. The net turnover during the day was Rs. 36587363.